<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>On the recommendations of Foreign Investment Promotion Board, the Government approves three FDI proposals involving FDI of 223.25 crore, and also approves one proposal listed as a tabled item involving an FDI of 420 crore</title>
    <link>https://www.taxtmi.com/news?id=16339</link>
    <description>Government approved three FDI proposals aggregating Rs. 223.25 crore and one tabled item involving Rs. 420 crore based on FIPB recommendations. Approvals covered subscription to convertible preference shares and secondary equity purchases in a pharmaceutical company, a slump-sale business transfer of pharmaceutical intellectual property, and up to 100% foreign investment in a new publishing company. Eight proposals across NBFC, telecom, wholesale trading, investing companies, pharma and defence were deferred; two proposals were rejected; and one filing was reclassified as a downstream intimation.</description>
    <language>en-us</language>
    <pubDate>Thu, 07 Jul 2016 10:32:07 +0530</pubDate>
    <lastBuildDate>Thu, 07 Jul 2016 10:32:07 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=434095" rel="self" type="application/rss+xml"/>
    <item>
      <title>On the recommendations of Foreign Investment Promotion Board, the Government approves three FDI proposals involving FDI of 223.25 crore, and also approves one proposal listed as a tabled item involving an FDI of 420 crore</title>
      <link>https://www.taxtmi.com/news?id=16339</link>
      <description>Government approved three FDI proposals aggregating Rs. 223.25 crore and one tabled item involving Rs. 420 crore based on FIPB recommendations. Approvals covered subscription to convertible preference shares and secondary equity purchases in a pharmaceutical company, a slump-sale business transfer of pharmaceutical intellectual property, and up to 100% foreign investment in a new publishing company. Eight proposals across NBFC, telecom, wholesale trading, investing companies, pharma and defence were deferred; two proposals were rejected; and one filing was reclassified as a downstream intimation.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Thu, 07 Jul 2016 10:32:07 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=16339</guid>
    </item>
  </channel>
</rss>